AstraZeneca Sues FDA As Firms Debut Generic Seroquel
AstraZeneca PLC on Tuesday sued the U.S. Food and Drug Administration over the agency's approval this week of a generic version of its antipsychotic medication Seroquel that several pharmaceutical firms announced...To view the full article, register now.
Already a subscriber? Click here to view full article